Retraction Retraction dated 2025-12-19
Click to view Retraction: https://doi.org/10.1038/s41366-025-02006-x
Retraction Retraction dated 2025-12-19
Click to view Retraction: https://doi.org/10.1038/s41366-025-02006-x
-
Authors
Naude, James
Zentner, Ali
Suresh, Priya
Bittman, Jesse
Khan, Nadia A. https://orcid.org/0000-0001-9823-6617
- License Information
-
More Information
Article History
Received: 20 July 2023
Revised: 25 March 2024
Accepted: 19 April 2024
First Online: 9 May 2024
Change Date: 16 May 2025
Change Type: Update
Change Details: Editor’s Note: Readers are alerted that concerns have been raised regarding the statistical analysis presented in this article. Further editorial action will be taken if appropriate once the assessment of these concerns is complete and all parties have been given an opportunity to respond in full.
Change Date: 19 December 2025
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1038/s41366-025-02006-x
Competing interests
: No funding was obtained for the current study. NAK, JN, and PS declare no conflicts of interest for this study. NAK is a volunteer board member of the International Society of Hypertension. JB received educational grant funding from Bayer; speaker fees from Novo Nordisk, Bausch Health and Astra Zeneca; advisory board of Novo Nordisk, Bausch Health and Bayer Inc. AZ received educational programme grant funding from Novo Nordisk and Bausch Health; speaker fees from Novo Nordisk, Bausch Health and Eli Lilly; past advisory board of Eli Lilly.
